Effect of secukinumab dose escalation on MRI-detected inflammation and structural damage in axial spondyloarthritis: a clinical, investigator-initiated, treat-to-target study (TRACE).

Vladimirova N, Østergaard M, Seven S, Møller JM, Jensen B, Østgård R, Poggenborg R, Madsen OR, Hendricks O, Brix L, Georgiadis S, Pedersen SJ

Open source

DOI: 10.1136/rmdopen-2026-006774
Published: 2026 Apr 10
Container: RMD open
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/rmdopen-2026-006774,
  title = {Effect of secukinumab dose escalation on MRI-detected inflammation and structural damage in axial spondyloarthritis: a clinical, investigator-initiated, treat-to-target study (TRACE).},
  author = {Vladimirova N and Østergaard M and Seven S and Møller JM and Jensen B and Østgård R and Poggenborg R and Madsen OR and Hendricks O and Brix L and Georgiadis S and Pedersen SJ},
  year = {2026},
  journal = {RMD open},
  doi = {10.1136/rmdopen-2026-006774},
  url = {https://doi.org/10.1136/rmdopen-2026-006774}
}

RIS

TY  - JOUR
TI  - Effect of secukinumab dose escalation on MRI-detected inflammation and structural damage in axial spondyloarthritis: a clinical, investigator-initiated, treat-to-target study (TRACE).
AU  - Vladimirova N
AU  - Østergaard M
AU  - Seven S
AU  - Møller JM
AU  - Jensen B
AU  - Østgård R
AU  - Poggenborg R
AU  - Madsen OR
AU  - Hendricks O
AU  - Brix L
AU  - Georgiadis S
AU  - Pedersen SJ
PY  - 2026
JO  - RMD open
DO  - 10.1136/rmdopen-2026-006774
UR  - https://doi.org/10.1136/rmdopen-2026-006774
ER  -

APA

N, V., M, Ø., S, S., JM, M., B, J., R, Ø., R, P., OR, M., O, H., L, B., S, G., & SJ, P. (2026). Effect of secukinumab dose escalation on MRI-detected inflammation and structural damage in axial spondyloarthritis: a clinical, investigator-initiated, treat-to-target study (TRACE).. RMD open. https://doi.org/10.1136/rmdopen-2026-006774

Source records

pubmed · retrieved 2026-09-26T01:41:18.592Z
europe-pmc · retrieved 2026-09-26T01:41:18.582Z
doaj · retrieved 2026-09-26T01:41:18.603Z